Clinical Trial Update: Sacral Neuromodulation (SNM) With InterStimTM for Bowel Dysfunction Following Surgery for Rectal Cancers With Sphincter Preservation [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating sacral neuromodulation (InterStim) for bowel dysfunction after rectal cancer surgery with sphincter preservation; study status termin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bowel Dysfunction
• Rectal Cancer

Drugs mentioned

• InterStim

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Rectal Cancer, for Bowel Dysfunction Following Surgery for Rectal Cancers | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2017-12-13